You Do Not Know What Is on the Network
Biomed spreadsheets go stale within weeks. Devices get plugged in, moved between wards, and never inventoried.
Unpatched devices on your EHR network are a route to PHI.
Biomed spreadsheets go stale within weeks. Devices get plugged in, moved between wards, and never inventoried.
FDA-cleared firmware freezes the OS. Windows 7 and unsupported Linux stay in service for a decade after end-of-life.
A compromised ultrasound cart can talk to the EHR, PACS, and billing systems because nothing separates clinical VLANs.
Shared service accounts and vendor default passwords ship with the device and survive every maintenance visit.
Biomed says it is IT, IT says it is the vendor, and the vendor points at the service contract. The gap never closes.
We discover, segment, and monitor every device.
Live inventory, risk, and behaviour for every connected device across every ward and site.
Each result traces to a specific device security gap we closed.
Book a Live DemoPremarket obligations, postmarket monitoring, and the tooling that runs it.
Premarket and postmarket cybersecurity obligations, handled properly.
PHI protection and audit-ready evidence across the device estate.
Agentless device fingerprinting that never touches cleared firmware.
Clinical micro-segmentation that contains any single compromise.
Continuous anomaly detection tuned to clinical device traffic.
Every connected class across every care setting.
Unknown devices, unpatchable firmware, and flat clinical networks cost you every day — in PHI exposure, audit findings, and risk you cannot quantify. Device security is the control that pays for itself.
Book Device Security Demo
Discovery, risk scoring, segmentation, and monitoring for connected clinical devices.
No agents or firmware patching on cleared devices, so passive discovery and segmentation do the work.
No. Fingerprinting is passive, from mirrored traffic and existing DICOM, HL7, and CMMS records.
Manufacturers must submit a cybersecurity plan, SBOM, and patching commitment; hospitals must monitor.
Isolation: scoped clinical VLANs, allow-listed flows, NAC enforcement, behavioural monitoring.
Yes. We sync and reconcile with Nuvolo, Accruent, or your CMMS so biomed and IT share one inventory.
We quarantine at the network layer and correlate recall and CVE feeds against your live inventory.
Typically 8–12 weeks: discovery, then segmentation design, then monitoring go-live from week 8.